Bliss GVS Pharma Regulatory Approval

Financial Results

Bliss GVS Pharma Q2 FY27 Results: Net Profit ₹53.3 Cr, Up 86.4% YoY

Bliss GVS Pharma Ltd reported revenue from operations of ₹313.4 Cr (+28.2% YoY) and net profit of ₹53.3 Cr (+86.4% YoY) for Q2 FY27.

Key figure

Net profit ₹53.3 Cr · +86.4% YoY

Employee Stock Options

Bliss GVS Pharma Employee Stock Options

Bliss GVS Pharma seeks shareholder approval via postal ballot for new employee stock option plans 2026. Up to 26,50,000 options are proposed; voting closes November 27, 2026.

Board Meeting Date

Bliss GVS Pharma Board Meeting Date

Bliss GVS Pharma Ltd scheduled a board meeting for October 29, 2026, to approve the company's unaudited financial results for the quarter ending September 30, 2026.

Other Announcement

Bliss GVS Pharma Other Announcement

Bliss GVS Pharma Ltd has filed its quarterly shareholding pattern report for the period ended September 30, 2026.

Annual General Meeting

Bliss GVS Pharma Annual General Meeting

Bliss GVS Pharma has issued a postal ballot notice to seek member approval for the appointment of three directors. This follows a recent change in control.

Employee Stock Options

Bliss GVS Pharma Employee Stock Options

Bliss GVS Pharma Limited allotted 53,500 equity shares under its Employee Stock Option Plan (ESOP). This issuance increases the company's total paid-up share capital.

Regulatory ApprovalEmmbi Industries Ltd EMMBIAlfa AlertAn Alfa Alert is ALFA Finder's top-priority alert: filings that can move a stock, such as orders, fund raises and approvals, sent to subscribers on Telegram within seconds of reaching the exchange.

Emmbi Industries Regulatory Approval

SEBI exempted the Makrand and Rinku Appalwar business trusts from SAST takeover rules for an internal family share transfer. Control and promoter shareholding remain unchanged.

Regulatory ApprovalJohn Cockerill India Ltd COCKERILLAlfa AlertAn Alfa Alert is ALFA Finder's top-priority alert: filings that can move a stock, such as orders, fund raises and approvals, sent to subscribers on Telegram within seconds of reaching the exchange.

John Cockerill India Regulatory Approval

John Cockerill India received Reserve Bank of India approval for acquiring shares of John Cockerill Metals International SA. This allows the company to proceed with the share-swap acquisition.

Regulatory ApprovalGland Pharma Ltd GLANDAlfa AlertAn Alfa Alert is ALFA Finder's top-priority alert: filings that can move a stock, such as orders, fund raises and approvals, sent to subscribers on Telegram within seconds of reaching the exchange.

Gland Pharma Regulatory Approval

Gland Pharma received USFDA approval for Methylprednisolone Acetate Injectable Suspension USP in multiple vial formats. The product is bioequivalent to Pfizer's Depo-Medrol in a ~$214M US market.

Regulatory ApprovalCity Union Bank Ltd CUBAlfa AlertAn Alfa Alert is ALFA Finder's top-priority alert: filings that can move a stock, such as orders, fund raises and approvals, sent to subscribers on Telegram within seconds of reaching the exchange.

City Union Bank Regulatory Approval

City Union Bank disclosed RBI approval for appointing Shri Sankaran G as Executive Director (Whole-time Director) for three years. The board appointment and formal disclosures will follow later.

Execution

Three years from the date of taking charge

Regulatory ApprovalLupin Ltd LUPINAlfa AlertAn Alfa Alert is ALFA Finder's top-priority alert: filings that can move a stock, such as orders, fund raises and approvals, sent to subscribers on Telegram within seconds of reaching the exchange.

Lupin Regulatory Approval

Lupin received US FDA approval for its generic Amifampridine Tablets 10 mg ANDA. As a first-to-file applicant, it is eligible for 180-day shared generic exclusivity.

Regulatory ApprovalSom Distilleries & Breweries Ltd SDBLAlfa AlertAn Alfa Alert is ALFA Finder's top-priority alert: filings that can move a stock, such as orders, fund raises and approvals, sent to subscribers on Telegram within seconds of reaching the exchange.

Som Distilleries & Breweries Regulatory Approval

Som Distilleries received manufacturing licences for its Bhopal plant from the Madhya Pradesh Excise Department, plus product label and rate approvals. Manufacturing and sales are expected to resume soon.